Clinical Trial

CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry

Recruiting
View on ClinicalTrials.gov →
Summary
Prospective observational registry focusing on an adolescent cohort diagnosed with severe alopecia areata,receiving routine care from dermatology providers. Visit schedules for patients will be determined by the provider in accordance with routine clinical care, and any prescriptions provided to patients will adhere to product availability and local prescribing guidelines/regulations in the country where the participating registry site is located.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-19; most recent amendment 2026-02-05.
Status change: Enrolling by Invitation → Recruiting 2025-01-08
Trial Details
NCT Number NCT06562270
Lead Sponsor CorEvitas
Conditions Alopecia Areata
Enrollment 1,500 participants
Start Date 2024-03-07
Primary Completion 2099-12-31 (estimated)
Study Completion 2099-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-09